A modern approach to CSF analysis: Pathophysiology, clinical application, proof of concept and laboratory reporting

Clinical Neurology and Neurosurgery

Volumn 111, Issue 4, 2009, Pages 313-318

  Regeniter, Axel ^a   Kuhle, Jens ^a   Mehling, Matthias ^a   Möller, Helgard ^b   Wurster, Ulrich ^c   Freidank, Heike ^a   Siede, Werner H ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b KLINIKUM LIPPE DETMOLD   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cerebrospinal fluid analysis; Knowledge based system; Laboratory reporting

Indexed keywords

BIOCHEMICAL MARKER; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

BIOCHEMISTRY; BLOOD CEREBROSPINAL FLUID BARRIER; BLOOD SAMPLING; CEREBROSPINAL FLUID ANALYSIS; CLINICAL LABORATORY; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; INFORMATION PROCESSING; KNOWLEDGE BASE; LABORATORY DIAGNOSIS; LEUKOCYTE COUNT; MEDICAL SOCIETY; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; REVIEW; STATISTICAL ANALYSIS;

GERMANY; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LABORATORY TECHNIQUES AND PROCEDURES; LEUKOCYTE COUNT; NERVOUS SYSTEM DISEASES;

EID: 63449142605     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2008.12.004     Document Type: Review

References (36)

1. Boon J.M., Abrahams P.H., Meiring J.H., and Welch T. Lumbar puncture: anatomical review of a clinical skill. Clin Anat 17 October (7) (2004) 544-553
2. Armon C., and Evans R.W. Addendum to assessment: prevention of post-lumbar puncture headaches: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 65 August 23 (4) (2005) 510-512
3. Reiber H., and Peter J.B. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci 184 March 1 (2) (2001) 101-122
4. Sindic C.J., Van Antwerpen M.P., and Goffette S. The intrathecal humoral immune response: laboratory analysis and clinical relevance. Clin Chem Lab Med 39 April (4) (2001) 333-340
5. Petereit H., Sindern E., and Wick M. Liquordiagnostik: Leitlinien und Methodenkatalog der Deutschen Gesellschaft für Liquordiagnostik und Klinische Neurochemie (2007), Springer, Berlin
6. Regeniter A., Steiger J.U., Scholer A., Huber P.R., and Siede W.H. Windows to the ward: graphically oriented report forms. Presentation of complex, interrelated laboratory data for electrophoresis/immunofixation, cerebrospinal fluid, and urinary protein profiles. Clin Chem 49 January (1) (2003) 41-50
7. Steele R.W., Marmer D.J., O'Brien M.D., Tyson S.T., and Steele C.R. Leukocyte survival in cerebrospinal fluid. J Clin Microbiol 23 May (5) (1986) 965-966
8. Kieslich M., Fiedler A., Driever P.H., Weis R., Schwabe D., and Jacobi G. Lyme borreliosis mimicking central nervous system malignancy: the diagnostic pitfall of cerebrospinal fluid cytology. Brain Dev 22 September (6) (2000) 403-406
9. Zettl U.K., Lehmitz R., and Mix E. Klinische Liquordiagnostik (2005), de Gruyter, Berlin
10. Wildemann B., and Brettschneider J. Neurologische Labordiagnostik (2006), Thieme, Stuttgart
11. Kluge H., Wieczorek V., Linke E., Zimmermann K., and Witte O.W. Atlas of CSF Cytology (2007), Thieme Verlag, Stuttgart
12. Pfausler B., Beer R., Engelhardt K., Kemmler G., Mohsenipour I., and Schmutzhard E. Cell index--a new parameter for the early diagnosis of ventriculostomy (external ventricular drainage)-related ventriculitis in patients with intraventricular hemorrhage?. Acta Neurochir (Wien) 146 May (5) (2004) 477-481
13. Shah K.H., and Edlow J.A. Distinguishing traumatic lumbar puncture from true subarachnoid hemorrhage. J Emerg Med 23 July (1) (2002) 67-74
14. Edlow J.A. Diagnosis of subarachnoid hemorrhage. Neurocrit Care 2 2 (2005) 99-109
15. Beetham R. Recommendations for CSF analysis in subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 75 April (4) (2004) 528
16. Gunawardena H., Beetham R., Scolding N., and Lhatoo S.D. Is cerebrospinal fluid spectrophotometry useful in CT scan-negative suspected subarachnoid haemorrage?. Eur Neurol 52 4 (2004) 226-229
17. Petzold A., Keir G., and Sharpe L.T. Spectrophotometry for xanthochromia. N Engl J Med 351 October 14 (16) (2004) 1695-1696
18. National guidelines for analysis of cerebrospinal fluid for bilirubin in suspected subarachnoid haemorrhage. Ann Clin Biochem 2003; 40(September, Pt 5):481-8.
19. Kappos L., and Dommasch D. Intracranial aneurysms. N Engl J Med 336 June 12 (24) (1997) 1758
20. Keir G., Tasdemir N., and Thompson E.J. Cerebrospinal fluid ferritin in brain necrosis: evidence for local synthesis. Clin Chim Acta 216 July 16 (1-2) (1993) 153-166
21. Watson I.D., Beetham R., Fahie-Wilson M.N., Holbrook I.B., and O'Connell D.M. What is the role of cerebrospinal fluid ferritin in the diagnosis of subarachnoid haemorrhage in computed tomography-negative patients?. Ann Clin Biochem 45 March (Pt 2) (2008) 189-192
22. Suzuki H., Muramatsu M., Tanaka K., Fujiwara H., Kojima T., and Taki W. Cerebrospinal fluid ferritin in chronic hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurol 253 September (9) (2006) 1170-1176
23. Thompson E.J. Proteins of the Cerebrospinal Fluid (2nd Edition). Analysis & Interpretation in the Diagnosis and Treatment of Neurological Disease (2005), Elsevier, Amsterdam
24. Wurster U. Protein gradients in the cerebrospinal fluid and the calculation of intracerebral IgG synthesis. J Neuroimmunol 20 December (2-3) (1988) 233-235
25. Reiber H. Flow rate of cerebrospinal fluid (CSF)--a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases [see comments]. J Neurol Sci 122 April (2) (1994) 189-203
26. Freedman M.S., Thompson E.J., Deisenhammer F., Giovannoni G., Grimsley G., Keir G., et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol 62 June (6) (2005) 865-870
27. Wurster U. Elektrophoreseverfahren - Nachweis und Bedeutung von oligoklonalen Banden. In: Zettl K., Lehmitz R., and Eilhard M. (Eds). Klinische Liquordiagnostik (2005), de Gruyter, Berlin 208-238
28. Andersson M., Alvarez-Cermeno J., Bernardi G., Cogato I., Fredman P., Frederiksen J., et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 57 August (8) (1994) 897-902
29. Mehling M., Kuhle J., and Regeniter A. 10 most commonly asked questions about cerebrospinal fluid characteristics in demyelinating disorders of the central nervous system. Neurologist 14 January (1) (2008) 60-65
30. Sindic C.J. CSF analysis in multiple sclerosis. Acta Neurol Belg 94 2 (1994) 103-111
31. Halperin J.J., Logigian E.L., Finkel M.F., and Pearl R.A. Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Quality Standards Subcommittee of the American Academy of Neurology. Neurology 46 March (3) (1996) 619-627
32. Keller T.L., Halperin J.J., and Whitman M. PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients. Neurology 42 January (1) (1992) 32-42
33. Picha D., Moravcova L., Zdarsky E., Maresova V., and Hulinsky V. PCR in lyme neuroborreliosis: a prospective study. Acta Neurol Scand 112 November (5) (2005) 287-292
34. Bednarova J. Cerebrospinal-fluid profile in neuroborreliosis and its diagnostic significance. Folia Microbiol (Praha) 51 6 (2006) 599-603
35. Tumani H., Nolker G., and Reiber H. Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis. Neurology 45 9 (1995) 1663-1670
36. Reiber H., Otto M., Trendelenburg C., and Wormek A. Reporting cerebrospinal fluid data: knowledge base and interpretation software. Clin Chem Lab Med 39 April (4) (2001) 324-332